Gapping up
In reaction to strong earnings/guidance: AKRX +10.8%, NQ +9.9%, LEU +1.3%
M&A news: MDVN +1.5% (TheDailyMail discussed takeover speculation surrounding Medivation, with RHHBY, AZN, & SNY among rumored potential suitors)
Select mining stocks trading higher: DRD +5.3%, AU +3.6%, HMY +2.3%, ABX +1.5%, GDX +1.1%
Other news: CLDN +4.3% (Celladon announces results of special shareholders meeting, approval of merger, 1:15 reverse stock split, & company name change ), SHAK +3.6% (still checking), VSLR +2.7% (closes a $200 mln term facility to be used for residential solar projects), IMMY +2.6% (Management discloses 6.4% passive stake) AFFX +1.8% (Origin Technologies provides additional information to Affymetrix Board; Reiterates commitment to acquire Affymetrix for $16.10 per share in cash), VRX +1.8% (cont vol pre-mkt), AAC +1.4% (confirms the dismissal of second degree murder charges against it and various of its executives), ABMD +1.3% (Abiomed comes to agreement with the FDA on the indication for use for emergency patients suffering from cardiogenic shock following acute myocardial infarction or cardiac surgery for the Pre-Market Approval for the Impella devices), SLW +0.8% (enters into Early Deposit Precious Metals Purchase Agreement with Panoro Minerals), .
Analyst comments: ZG +2.3% (upgraded to Outperform from Sector Perform at RBC Capital Mkts), WYNN +1.8% (upgraded to Overweight from Equal-Weight at Morgan Stanley), SLM +1.7% (upgraded to Buy at DA Davidson), ANF +1.4% (Added to Franchise Pick List at Jefferies)